Skip to main content
Contact Us
Subscribe
E-Edition
65°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cormedix Inc
(NQ:
CRMD
)
3.670
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
3.670
Bid (Size)
3.660 (4)
Ask (Size)
3.760 (2)
Prev. Close
3.670
Today's Range
3.670 - 3.670
52wk Range
2.710 - 6.090
Shares Outstanding
38,086,437
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CorMedix's DefenCath Aims to Tackle Catheter-Related Blood Stream Infections: Analyst
August 10, 2023
RBC Capital Markets initiated coverage on CorMedix Inc (NASDAQ: CRMD) with an Outperform rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
Performance
YTD
-12.20%
-12.20%
1 Month
-11.99%
-11.99%
3 Month
-27.61%
-27.61%
6 Month
+0.27%
+0.27%
1 Year
+26.12%
+26.12%
More News
Read More
The Latest Analyst Ratings for Cormedix
August 10, 2023
Via
Benzinga
CorMedix (CRMD) Q2 2023 Earnings Call Transcript
August 08, 2023
Via
The Motley Fool
Why Shares of CorMedix Are Slumping Thursday
June 29, 2023
Via
The Motley Fool
Analyst Ratings for Cormedix
June 21, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Cormedix
May 16, 2023
Via
Benzinga
CorMedix (CRMD) Q1 2023 Earnings Call Transcript
May 15, 2023
Via
The Motley Fool
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 29, 2023
Via
Benzinga
Why Are Bank Stocks WFC, JPM, BAC Up Today?
June 29, 2023
Via
InvestorPlace
Recap: Cormedix Q1 Earnings
May 15, 2023
Via
Benzinga
Preview: Cormedix's Earnings
May 12, 2023
Via
Benzinga
Expert Ratings for Cormedix
March 31, 2023
Via
Benzinga
FREY Stock Price Prediction: Is Freyr Battery Really Worth $13?
June 29, 2023
Via
InvestorPlace
Why Is Cormedix (CRMD) Stock Down 23% Today?
June 29, 2023
Via
InvestorPlace
Why Cormedix (CRMD) Stock Is Getting Hammered
June 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
June 29, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 29, 2023
Via
InvestorPlace
As CorMedix's DefenCath Moves Forward On Regulatory Path, Analyst Boosts Price Target
May 19, 2023
Via
Benzinga
Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock?
May 04, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Via
InvestorPlace
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
April 26, 2023
Via
InvestorPlace
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.